Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of April 8, 2025 • 8:31 PM ET

Date/Time Source News Release
04/07/2025 01:26 PM EDT GlobeNewswire AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market
04/04/2025 04:45 PM EDT GlobeNewswire AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
04/01/2025 09:15 AM EDT GlobeNewswire AI-Media Partners with AudioShake to Revolutionize Live Sports Audio and AI Voice Translation
03/27/2025 12:43 PM EDT GlobeNewswire LEXI Voice is Coming: AI-Media Releases Groundbreaking AI Voice Translation at NAB 2025
03/27/2025 08:05 AM EDT GlobeNewswire AIM ImmunoTech Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
03/11/2025 08:45 AM EDT GlobeNewswire AIM ImmunoTech Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference
02/28/2025 08:45 AM EST GlobeNewswire AIM announces Paul Goepfert, MD, as the principal investigator for the planned clinical study of Ampligen and FluMist as a vaccine for avian influenza
02/27/2025 09:15 AM EST GlobeNewswire AI-Media Partners with the England and Wales Cricket Board for Cutting-Edge Captioning Solution
02/26/2025 01:20 PM EST GlobeNewswire AIM ImmunoTech Announces NYSE American Acceptance of Plan to Regain Listing Compliance
02/26/2025 08:30 AM EST GlobeNewswire AIM ImmunoTech Appoints David Chemerow to Board of Directors as an Independent Director
Page

Additional News

As of April 8, 2025 • 8:31 PM ET

Date/Time Source News Release
04/04/2025 04:55 PM EDT SeekingAlpha AIM ImmunoTech receives NYSE American notice of delisting and appeal
04/01/2025 05:21 PM EDT SeekingAlpha AIM ImmunoTech files $100M mixed securities shelf
04/01/2025 09:19 AM EDT SeekingAlpha AIM ImmunoTech Inc. (AIM) Q4 2024 Earnings Call Transcript
03/27/2025 08:49 AM EDT SeekingAlpha AIM ImmunoTech GAAP EPS of -$0.31 misses by $0.01, revenue of $0.17M misses by $0.03M
03/26/2025 08:10 AM EDT Zacks OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates
03/19/2025 08:10 AM EDT Zacks MediWound (MDWD) Reports Q4 Loss, Tops Revenue Estimates
01/23/2025 05:42 PM EST SeekingAlpha AIM ImmunoTech files to sell units, no amount given
01/17/2025 12:00 PM EST Zacks AIM ImmunoTech (AIM) Upgraded to Strong Buy: What Does It Mean for the Stock?
12/17/2024 05:01 PM EST SeekingAlpha AIM Immunotech receives non-compliance notice from NYSE American
11/15/2024 10:32 AM EST SeekingAlpha AIM ImmunoTech Inc. (AIM) Q3 2024 Earnings Call Transcript
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.